Market Size of Medical Marijuana Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 21.13 Billion |
Market Size (2029) | USD 44.47 Billion |
CAGR (2024 - 2029) | 16.05 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Medical Marijuana Market Analysis
The Medical Marijuana Market size is estimated at USD 21.13 billion in 2024, and is expected to reach USD 44.47 billion by 2029, growing at a CAGR of 16.05% during the forecast period (2024-2029).
The major factors driving the medical marijuana market include the increasing number of countries legalizing the use of medical marijuana, the trend of producing edible products with Cannabis, and favorable reimbursement environment and government support in selected countries.
The increasing legalization of the use of cannabis across the countries coupled with growing government initiatives are expected to fuel the growth of the studied market over the forecast period. For instance, according to a United Nations press release in June 2022, Cannabis legalization has accelerated daily use and related health impacts. It also stated that there is a rise in the manufacturing of cocaine and the expansion of synthetic drugs to new markets. Additionally, in June 2022, Luxembourg's government unveiled a draft law permitting adults to cultivate up to four cannabis plants at home for recreational use. Additionally, the law would sanction non-medical cannabis consumption within private residences. Also, in January 2022, the Delhi High Court stated that the use of Cannabis is not completely banned in India, and its medical and scientific use is allowed under the law.
Furthermore, the growing consumer shift towards the use of edible products prepared using cannabis is anticipated to fuel the market growth. For instance, in June 2023, a survey by New Frontier Data revealed a notable trend, about 69% of individuals aged 18 to 24, in the United States, prefer marijuana over alcohol in 2022. Notably, this shift isn't limited to the younger demographic; consumers up to age 44 are also increasingly embracing this change. Thus, the rising adoption of marijuana among the population raises its demand which in turn is anticipated to bolster the market growth over the forecast period.
Moreover, the adoption of key strategies such as partnerships and acquisitions has been improving the potential of marijuana in medical applications, which is expected to augment the market growth during the forecast period. For instance, in February 2022, tBombay Hemp Company, an agro-based enterprise, partnered with Poonthottam Ayurvedasram to unlock the ancient Ayurvedic potential of Cannabis through human reason. Together, they've launched 'AyurCann: Ayurvedic Cannabis Therapies,' marking Asia's pioneering Ayurvedic Cannabis Wellness Retreat.
Thus, owing to the factors above, the market studied is anticipated to grow over the analysis period. However, limited awareness of marijuana's dosage and medicinal properties, along with social stigma related to cannabis use, are likely to restrain market growth.
Medical Marijuana Industry Segmentation
As per the scope of the report, medical marijuana refers to the whole, unprocessed marijuana plant, or its basic extracts, used to treat several diseases and other related symptoms. Scientific studies show that chemical cannabinoids could help treat various diseases and symptoms, attracting several biopharmaceutical companies globally over the past two decades.
The medical marijuana market is segmented by formulation type, application, and geography. By formulation, the market is segmented into capsules, oils, and other formulation types. The application segment is bifurcated into chronic pain, arthritis, migraine, cancer, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers the value (in USD) for the above segments.
By Formulation Type | |
Capsules | |
Oils | |
Other Formulation Types (Drops, Gel) |
By Application | |
Chronic Pain | |
Arthritis | |
Migraine | |
Cancer | |
Other Applications |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Medical Marijuana Market Size Summary
The medical marijuana market is poised for significant growth, driven by increasing legalization across various countries and a shift towards cannabis-infused edible products. Government support and favorable reimbursement environments in select regions are further propelling market expansion. The trend of integrating cannabis into edible products is gaining traction, particularly among younger consumers, which is expected to boost demand. Strategic partnerships and acquisitions are enhancing the potential of medical marijuana in therapeutic applications, contributing to market growth. Despite these positive trends, challenges such as limited awareness of cannabis's medicinal properties and social stigma may hinder market progress.
North America is a key region in the medical marijuana market, with its share expected to grow steadily due to ongoing legalization efforts and a rising preference for cannabis-infused edibles. The establishment of cannabis research centers and regulatory frameworks is supporting market development. The region's market is characterized by robust sales and consumption, particularly of THC-infused products. The competitive landscape is moderately concentrated, with major companies engaging in strategic collaborations to expand their global presence. Overall, the market is set to experience substantial growth, driven by increasing adoption, research initiatives, and regulatory advancements.
Medical Marijuana Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Number of Countries Legalizing the Use of Medical Marijuana
-
1.2.2 Trend of Producing Edible Products with Cannabis
-
1.2.3 Favorable Reimbursement Environment and Government Support in Certain Countries
-
-
1.3 Market Restraints
-
1.3.1 Lack of Awareness about the Dosage and Medicinal Properties of Marijuana
-
1.3.2 Social Stigma Related to Cannabis Use
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - in USD)
-
2.1 By Formulation Type
-
2.1.1 Capsules
-
2.1.2 Oils
-
2.1.3 Other Formulation Types (Drops, Gel)
-
-
2.2 By Application
-
2.2.1 Chronic Pain
-
2.2.2 Arthritis
-
2.2.3 Migraine
-
2.2.4 Cancer
-
2.2.5 Other Applications
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 MiddlecEast and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Medical Marijuana Market Size FAQs
How big is the Medical Marijuana Market?
The Medical Marijuana Market size is expected to reach USD 21.13 billion in 2024 and grow at a CAGR of 16.05% to reach USD 44.47 billion by 2029.
What is the current Medical Marijuana Market size?
In 2024, the Medical Marijuana Market size is expected to reach USD 21.13 billion.